Impact of age on the prognostic value of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: Insights from the British cardiovascular intervention society

Catheterization and Cardiovascular Interventions

Volumn 85, Issue 6, 2015, Pages 944-951

  Kwok, Chun Shing ^a   Anderson, Simon G ^a,b   McAllister, Katherine S L ^c   Sperrin, Matthew ^c   O'Kane, Peter D ^d   Keavney, Bernard ^a,b   Nolan, James ^e   Myint, Phyo Kyaw ^f   Zaman, Azfar ^g   Buchan, Iain ^c   Ludman, Peter F ^h   De Belder, Mark A ⁱ   Mamas, Mamas A ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^e UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h QUEEN ELIZABETH HOSPITAL   (United Kingdom)

ⁱ JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

age; left ventricular function; PCI

Indexed keywords

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOGENIC SHOCK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PROGNOSIS; RANK SUM TEST; RETROSPECTIVE STUDY; REVASCULARIZATION; UNITED KINGDOM; ADVERSE EFFECTS; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; DIAGNOSTIC IMAGING; ETIOLOGY; HOSPITAL MORTALITY; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED KINGDOM; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84928501024     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25732     Document Type: Article

References (28)

1. De Silva K, Webb I, Sicard P, Lockie T, Pattinson S, Redwood S, Perera D,. Does left ventricular function continue to influence mortality following contemporary percutaneous coronary intervention? Coron Artery Dis 2012; 23: 155-161.
2. Keelan PC, Johnston JM, Koru-Sengul T, Detre KM, Williams DO, Slater J, Block PC, Holmes DR Jr., Dynamic Registry I., Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions or=50% having percutaneous coronary revascularization. Am J Cardiol 2003; 91: 1168-1172.
3. Wallace TW, Berger JS, Wang A, Velazquez EJ, Brown DL,. Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention. Am J Cardiol 2009; 103: 355-360.
4. Sardi GL, Gaglia MA Jr., Maluenda G, Torguson R, Laynez-Carnicero A, Ben-Dor I, Hauville C, Xue Z, Suddath WO, Kent KM, et al. Outcome of percutaneous coronary intervention utilizing drug-eluting stents in patients with reduced left ventricular ejection fraction. Am J Cardiol 2012; 109: 344-351.
5. Holper EM, Blair J, Selzer F, Detre KM, Jacobs AK, Williams DO, Vlachos H, Wilensky RL, Coady P, Faxon DP, et al. The impact of ejection fraction on outcomes after percutaneous coronary intervention in patients with congestive heart failure: An analysis of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry and Dynamic Registry. Am Heart J 2006; 151: 69-75.
6. Daneault B, Genereux P, Kirtane AJ, Witzenbichler B, Guagliumi G, Paradis JM, Fahy MP, Mehran R, Stone GW,. Comparison of three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus >/= 40% (from the HORIZONS-AMI trial). Am J Cardiol 2013; 111: 12-20.
7. Mamas MA, Anderson SG, O'Kane PD, Keavney B, Nolan J, Oldroyd KG, Perera D, Redwood S, Zaman A, Ludman PF, et al. Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society. Eur Heart J 2014. [Epub ahead of print]
8. Farooq V, Vergouwe Y, Raber L, Vranckx P, Garcia-Garcia H, Diletti R, Kappetein AP, Morel MA, de Vries T, Swart M, et al. Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: The Logistic Clinical SYNTAX score. Eur Heart J 2012; 33: 3098-3104.
9. Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, Shaw RE, Roe MT, Ho KK, Klein LW, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: Results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol 2010; 55: 1923-1932.
10. Wu C, Camacho FT, King SB III, Walford G, Holmes DR Jr., Stamato NJ, Berger PB, Sharma S, Curtis JP, Venditti FJ, et al. Risk stratification for long-term mortality after percutaneous coronary intervention. Circ Cardiovasc Interv 2014; 7: 80-87.
11. Radovanovic D, Seifert B, Urban P, Eberli FR, Rickli H, Bertel O, Puhan MA, Erne P, Investigators AP,. Validity of Charlson comorbidity index in patients hospitalised with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart 2014; 100: 288-294.
12. Bainey KR, Selzer F, Cohen HA, Marroquin OC, Holper EM, Graham MM, Williams DO, Faxon DP,. Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2012; 109: 195-201.
13. Belardi J, Manoharan G, Albertal M, Widimsky P, Neumann FJ, Silber S, Leon MB, Saito S,. The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent. Catheter Cardiovasc Interv 2014. doi: 10.1002/ccd.25334. [Epub ahead of print]
14. Rao SV, Hess CN, Dai D, Green CL, Peterson ED, Douglas PS,. Temporal trends in percutaneous coronary intervention outcomes among older patients in the United States. Am Heart J 2013; 166: 273-281 e4.
15. Brennan JM, Curtis JP, Dai D, Fitzgerald S, Khandelwal AK, Spertus JA, Rao SV, Singh M, Shaw RE, Ho KK, et al. Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: Results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv 2013; 6: 790-799.
16. Davies M, Hobbs F, Davis R, Kenkre J, Roalfe AK, Hare R, Wosornu D, Lancashire RJ,. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study. Lancet 2001; 358: 439-444.
17. Ludman PF, British Cardiovascular Intervention S. British Cardiovascular Intervention Society Registry for audit and quality assessment of percutaneous coronary interventions in the United Kingdom. Heart 2011; 97: 1293-1297.
18. Mamas MA, Ratib K, Routledge H, Neyses L, Fraser DG, de Belder M, Ludman PF, Nolan J, British Cardiovascular Intervention S, the National Institute for Cardiovascular Outcomes R. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: Are the results of randomized trials achievable in clinical practice? JACC Cardiovasc Interv 2013; 6: 698-706.
19. Mamas MA, Anderson SG, Ratib K, Routledge H, Neyses L, Fraser DG, Buchan I, de Belder MA, Ludman P, Nolan J, et al. Arterial access site utilization in cardiogenic shock in the United Kingdom: Is radial access feasible? Am Heart J 2014; 167: 900-8 e1.
20. Cuzick J,. A Wilcoxon-type test for trend. Stat Med 1985; 4: 87-90.
21. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE,. Prevalence of heart failure and left ventricular dysfunction in the general population: The Rotterdam study. Eur Heart J 1999; 20: 447-455.
22. Yousaf F, Collerton J, Kingston A, Kenny A, Davies K, Jagger C, Robinson L, Kirkwood TB, Keavney B,. Prevalence of left ventricular dysfunction in a UK community sample of very old people: The Newcastle 85+ study. Heart 2012; 98: 1418-1423.
23. Legrand VM, Garg S, Serruys PW, Virtanen KS, Szurawitzki G, Voudris V, Fontanelli A, Endersen K, Kranjec I, Rademaker T, et al. Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: Sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised arterial revascularisation therapy study Part I (ARTS-I) and Part II (ARTS-II). EuroIntervention 2011; 6: 838-845.
24. Gharacholou SM, Roger VL, Lennon RJ, Rihal CS, Sloan JA, Spertus JA, Singh M,. Comparison of frail patients versus nonfrail patients >/=65 years of age undergoing percutaneous coronary intervention. Am J Cardiol 2012; 109: 1569-1575.
25. Singh M, Rihal CS, Lennon RJ, Spertus JA, Nair KS, Roger VL,. Influence of frailty and health status on outcomes in patients with coronary disease undergoing percutaneous revascularization. Circ Cardiovasc Qual Outcomes 2011; 4: 496-502.
26. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA,. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: A report of the American college of cardiology foundation appropriate use criteria task force, society for cardiovascular angiography and interventions, society of thoracic surgeons, American association for thoracic surgery, American heart association, American society of nuclear cardiology, and the society of cardiovascular computed tomography. J Am Coll Cardiol 2012; 59: 857-881.
27. Task Force on Myocardial Revascularization of the European Society of C, the European Association for Cardio-Thoracic S, European Association for Percutaneous Cardiovascular I, Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-2555.
28. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol 2013; 62: e147-e239.